RECRUITING

A Survey to Assess Participants' and Physicians' Knowledge, Attitudes and Behavior When Using NATPARA

Description

This main aim of this study is to check the level of knowledge and assess attitudes and behaviors of both participants and prescribing physicians regarding the risks and safe use of NATPARA. The survey will be done via internet, telephone, or paper and participants will be able to choose the method that is preferred. No study medicines will be provided to patients in this study.

Study Overview

Study Details

Study overview

This main aim of this study is to check the level of knowledge and assess attitudes and behaviors of both participants and prescribing physicians regarding the risks and safe use of NATPARA. The survey will be done via internet, telephone, or paper and participants will be able to choose the method that is preferred. No study medicines will be provided to patients in this study.

Quantitative Testing of Patient and Healthcare Provider Knowledge, Attitudes, and Behavior About NATPARA® (Parathyroid Hormone) for Injection, for Subcutaneous Use

A Survey to Assess Participants' and Physicians' Knowledge, Attitudes and Behavior When Using NATPARA

Condition
Hypoparathyroidism
Intervention / Treatment

-

Contacts and Locations

Lexington

Shire-NPS Pharmaceuticals, INC. (Shire now part of Takeda), Lexington, Massachusetts, United States,

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * A caregiver may participate in this survey on behalf of a participant who is a part of the SUP Program and who is eligible but unable to complete the survey.
  • * Respondents who do not agree to participate in the survey will be excluded.
  • * Survey respondents who have been employed or whose immediate family members have been employed by NPS, Shire, Takeda, United BioSource LLC, (UBC), or the Food and Drug Administration (FDA) are not eligible to participate in the survey and will be excluded.
  • * Respondents who reported having a conflict of interest will be excluded.
  • * Respondents who are not part of the SUP program will be excluded.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Shire,

Study Director, STUDY_DIRECTOR, Shire

Study Record Dates

2024-12-31